KABUL: On Tuesday 23 November the Taliban Regime in Afghanistan has signed a USD 450,000,000 deal with Australian company Cpharm in the cannabis processing industry in Afghanistan.
Afghan Ministry of Interior Affairs posted on social media informing that Cpharm Company has agreed for its investment of worth more than $400 million aiming to start the production of cannabis in Afghanistan setting up factories.
This cannabis processing may lead to the legalized drug trade by the Islamic Emirate. But it is strange that the Australian business company with the name Cpharm later denied its involvement with the project.
Cpharm is an Australian company that says that it has no idea about what deal is Taliban talking about it says that various media articles have been stating the news of the involvement in the investment of cannabis supply but there is nothing like this.
The Cpharm Pty Ltd Australia does not manufacture or supply anything but the company provides a service of media advice to the pharmaceutical industry within the country of Australia. In a press release, the company states that it has no ARTG and clearly says it has no connection with the Taliban or cannabis.
The press release further reads that the company is unaware about from where the release by Taliban of such a deal has come out and strictly mentions it should not be connected with the company Cpharm Pty Ltd Australia.
Earlier, Taliban's spokesperson Qari Saeed Khosty who took over the power from the Afghan government in summer 2021 after the withdrawal of the U.S. military had provided information through a Twitter thread about the supposed deal with the Australian Company.
According to a translation, Qari Saeed Khosty said that on Wednesday 24 November the higher officials from the Ministry of Interior's Counter-Narcotics Department organized a meeting with the representative of the Australian company Cpharm. He informed that the company wishes to build a cannabis processing plant in Afghanistan which will help in creating various cannabis products.